Subscribe
Health Decisions changing the game for women’s health clinical studies – Episode 59

FemTech Focus

Health Decisions changing the game for women’s health clinical studies – Episode 59

Dr. Andrea Lukes has an extensive career in women’s health ranging from being a board-certified OB/GYN to the Chief Medical Officer of Health Decisions. Dr. Lukes currently advises Health Decisions…
November 2, 2020
ADVERTISEMENT
EHRGo-THE FUTURE OF HEALTHCARE EDUCATION

Health Decisions changing the game for women’s health clinical studies – Episode 59

Dr. Andrea Lukes has an extensive career in women’s health ranging from being a board-certified OB/GYN to the Chief Medical Officer of Health Decisions. Dr. Lukes currently advises Health Decisions on the development and implementation of research protocols and communications to the FDA. Dr. Lukes has conducted and/or overseen more than 80 clinical trials of investigational women’s health products over the last ten years. Her articles have appeared in journals including the Obstetrics and Gynecology, the American Journal of Obstetrics and Gynecology, the International Journal of Women’s Health, Cancer and Current Medical Research & Opinion and Drug Safety just to name a few. She also founded the Carolina Women’s Research & Wellness Center, co-founded and served as the Director of Gynecology for the Women’s Hemostasis and Thrombosis Clinic at the Duke University Medical Center and founded and chaired the OB/GYN Alliance, an online network of 8,000 OB/GYN physicians in the United States. We discussed heavy menstrual bleeding, clinical trials and barriers to getting women medical device getting approved.

Check out Health Decisions at healthdec.com
Rate, Review & Subscribe!

ADVERTISEMENT
EHRGo-THE FUTURE OF HEALTHCARE EDUCATION

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Proudly supported by:

cover
Medicines360 is constructing healthcare for women everywhere Dr. Jessica Grossman is the CEO of Medicines360, discusses increasing affordability and accessibility in women's health, equity in clinical studies, and demystifying birth control.